Kasia Nowok
Kasia has been working in the pharmaceutical industry, since 2006 in various regulatory affairs roles. Prior to her current Regulatory Intelligence position at UCB, Kasia had diverse responsibilities in European Human Regulatory Affairs lifecycle and development. Kasia received her master’s degree in chemistry from the University of Opole, Poland in 2004.
- Editorial
Patient evidence and engagement
Don’t we in Life Sciences excel at generating abbreviations and acronyms? For example, do you know your COA from your PED or PPI? Or PEE from PRO? If you don’t, an explanation will be forthcoming in this edition of the Regulatory Rapporteur.
- Interview
Every patient has a story to tell us
Dr Francesco Pignatti, Head of Oncology and Haematology at the EMA, discusses his career, his inspirations, and why it is important to involve patients in regulatory decisions.
- Journal
Digital and data-driven: information management at the EMA
Dr Hilmar Hamann, Head of Information Management Division at the EMA, discusses key milestones in his career, the challenges faced and his long-term visions for information management legislation
- Editorial
A new era of digital and data-driven innovations
Such significant advances in information management and technology are providing us with sophisticated tools and new ways of working
- Journal
Evolutions in patient healthcare at MHRA
Chief Safety Officer, Alison Cave discusses her role at the MHRA, key objectives and ambitions for the regulator.
- Meeting Report
HM6: Clinical trials of the future – patient orientated and digitally connected
Susan Bhatti started the session by welcoming everyone and clarifying that the aim of the meeting was to discuss how clinical trials can be transformed by using digital technologies to enrol and monitor patients, resulting in more inclusive, flexible, connected and patient-centred studies.
- Meeting Report
HM3: Evolution of EMA-EUnetHTA collaboration across decision makers
This session focused on the evolution of the European Medicines Agency (EMA) and The European Network for Health Technology Assessment (EUnetHTA) collaboration.